The Pharma industry is up 4.0% in the last week, with Eli Lilly up 10%. This means that the industry has gained 16% over the past year. Looking forward, earnings are forecast to grow by 24% annually.
Has the U.S. Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 16 Aug 2024 | US$2.0t | US$362.0b | US$21.9b | 17.3x | 91.7x | 5.5x |
Sun, 14 Jul 2024 | US$2.0t | US$357.7b | US$13.8b | 15.9x | 146.2x | 5.7x |
Tue, 11 Jun 2024 | US$1.9t | US$358.3b | US$14.1b | 19x | 138x | 5.4x |
Thu, 09 May 2024 | US$1.9t | US$358.2b | US$13.9b | 21x | 133.4x | 5.2x |
Sat, 06 Apr 2024 | US$1.9t | US$355.2b | US$22.7b | 24.7x | 82x | 5.2x |
Mon, 04 Mar 2024 | US$1.9t | US$355.3b | US$22.5b | 24.1x | 85x | 5.4x |
Wed, 31 Jan 2024 | US$1.8t | US$351.7b | US$24.9b | 28.7x | 71.3x | 5.1x |
Fri, 29 Dec 2023 | US$1.7t | US$375.2b | US$33.8b | 32.1x | 49.8x | 4.5x |
Sun, 26 Nov 2023 | US$1.7t | US$375.1b | US$33.9b | 26.2x | 48.8x | 4.4x |
Tue, 24 Oct 2023 | US$1.6t | US$382.7b | US$44.7b | 14.7x | 36.7x | 4.3x |
Thu, 21 Sep 2023 | US$1.7t | US$381.8b | US$43.9b | 18.3x | 39.1x | 4.5x |
Sat, 19 Aug 2023 | US$1.8t | US$381.6b | US$44.1b | 18.5x | 40.3x | 4.6x |
Mon, 17 Jul 2023 | US$1.7t | US$392.8b | US$60.2b | 18.3x | 27.7x | 4.2x |
Wed, 14 Jun 2023 | US$1.7t | US$392.8b | US$60.1b | 18.6x | 28.8x | 4.4x |
Fri, 12 May 2023 | US$1.7t | US$395.0b | US$57.5b | 20.3x | 30.3x | 4.4x |
Sun, 09 Apr 2023 | US$1.7t | US$401.2b | US$69.7b | 15.9x | 23.7x | 4.1x |
Tue, 07 Mar 2023 | US$1.6t | US$401.0b | US$69.4b | 17x | 22.7x | 3.9x |
Thu, 02 Feb 2023 | US$1.7t | US$403.0b | US$70.8b | 18x | 23.5x | 4.1x |
Sat, 31 Dec 2022 | US$1.8t | US$403.7b | US$70.7b | 16.8x | 24.8x | 4.3x |
Mon, 28 Nov 2022 | US$1.7t | US$403.7b | US$70.7b | 16.9x | 24.7x | 4.3x |
Wed, 26 Oct 2022 | US$1.7t | US$403.4b | US$72.1b | 13.5x | 22.9x | 4.1x |
Fri, 23 Sep 2022 | US$1.6t | US$403.0b | US$71.3b | 12.9x | 22x | 3.9x |
Sun, 21 Aug 2022 | US$1.7t | US$402.8b | US$70.1b | 15.3x | 23.7x | 4.1x |
Tue, 19 Jul 2022 | US$1.7t | US$392.4b | US$65.1b | 22x | 26.1x | 4.3x |
Thu, 16 Jun 2022 | US$1.6t | US$392.5b | US$64.7b | 20.6x | 24.3x | 4x |
Sat, 14 May 2022 | US$1.6t | US$392.5b | US$64.4b | 20.4x | 25.3x | 4.1x |
Mon, 11 Apr 2022 | US$1.7t | US$373.8b | US$60.7b | 22.4x | 28.5x | 4.6x |
Wed, 09 Mar 2022 | US$1.6t | US$373.6b | US$60.3b | 19.5x | 25.7x | 4.2x |
Fri, 04 Feb 2022 | US$1.6t | US$364.0b | US$40.7b | 21.6x | 39x | 4.4x |
Sun, 02 Jan 2022 | US$1.7t | US$361.1b | US$37.8b | 22.9x | 44x | 4.6x |
Tue, 30 Nov 2021 | US$1.5t | US$361.1b | US$38.1b | 22.6x | 40.6x | 4.3x |
Thu, 28 Oct 2021 | US$1.5t | US$341.0b | US$24.7b | 20.2x | 61.6x | 4.5x |
Sat, 25 Sep 2021 | US$1.5t | US$337.6b | US$25.8b | 22x | 58.3x | 4.5x |
Mon, 23 Aug 2021 | US$1.6t | US$338.5b | US$25.8b | 19.5x | 63x | 4.8x |
63x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 4.04% | |
Healthcare | 2.65% | |
Pharma | 3.99% | |
Pharma | 3.99% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
LLY Eli Lilly | US$931.58 | 10.2% +US$77.7b | 73.3% | PE114.2x | |
BMY Bristol-Myers Squibb | US$49.11 | 4.8% +US$4.6b | -21.0% | PS2.1x | |
TEVA Teva Pharmaceutical Industries | US$18.33 | 6.8% +US$1.3b | 92.7% | PS1.3x | |
ELAN Elanco Animal Health | US$14.58 | 12.2% +US$786.0m | 27.2% | PS1.6x | |
RPRX Royalty Pharma | US$27.41 | 4.8% +US$564.6m | -6.4% | PE18.2x |